These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4025722)

  • 21. Immunomodulation for the prevention of SPIDDM and LADA.
    Pozzilli P; Guglielmi C
    Ann N Y Acad Sci; 2006 Oct; 1079():90-8. PubMed ID: 17130536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-2 receptor-targeted immune therapy.
    Diamantstein T; Hahn HJ
    Immunol Ser; 1993; 59():295-318. PubMed ID: 8461395
    [No Abstract]   [Full Text] [Related]  

  • 23. [Diabetes mellitus type 1 (insulin-dependent). The etiopathogenetic aspects (II)].
    Guerra Vales JM; Damiano Rivero A
    Rev Clin Esp; 1995 Jul; 195(7):485-91. PubMed ID: 7667525
    [No Abstract]   [Full Text] [Related]  

  • 24. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
    Phillips BE; Giannoukakis N; Trucco M
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy of type I diabetes.
    Eisenbarth GS
    Diabetes Care; 1983; 6(5):521-3. PubMed ID: 6336348
    [No Abstract]   [Full Text] [Related]  

  • 26. T-cell regulation in murine and human autoimmune diabetes: the role of TH1 and TH2 cells.
    Heurtier AH; Boitard C
    Diabetes Metab; 1997 Nov; 23(5):377-85. PubMed ID: 9416429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunosuppression trials in type I diabetes].
    Feutren G; Boitard C; Assan R; Bach JF
    Journ Annu Diabetol Hotel Dieu; 1987; ():147-69. PubMed ID: 3302472
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of type 1 diabetes mellitus to preserve insulin secretion.
    Herold KC
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):93-111, ix. PubMed ID: 15053897
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunotherapy of autoimmune diseases.
    Bach JF
    Recenti Prog Med; 1988; 79(7-8):343-50. PubMed ID: 3059421
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunological features in the course of type 1 diabetes.
    Ilonen J; Mustonen A; Akerblom HK; Kouvalainen K
    Ann Clin Res; 1984; 16(2):64-73. PubMed ID: 6380389
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunotherapy of recent-onset type I diabetes mellitus].
    Assan R
    Ann Med Interne (Paris); 1985; 136(6):451-2. PubMed ID: 4083634
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic intervention in autoimmunity.
    Tisch R; Yang XD; McDevitt HO
    Behring Inst Mitt; 1994 Jul; (94):171-8. PubMed ID: 7998910
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunomodulating therapy in insulin-dependent diabetes mellitus: problems and new prospects].
    Galenok VA; Zhuk EA
    Ter Arkh; 1995; 67(12):80-4. PubMed ID: 8820069
    [No Abstract]   [Full Text] [Related]  

  • 34. Immune Interventions for Type 1 Diabetes Mellitus.
    Nambam B; Bratina N; Schatz D
    Diabetes Technol Ther; 2017 Feb; 19(S1):S74-S81. PubMed ID: 28192018
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytokine and immunosuppressive therapies of type 1 diabetes mellitus.
    Gottlieb PA; Hayward AR
    Endocrinol Metab Clin North Am; 2002 Jun; 31(2):477-95. PubMed ID: 12092462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive medicine: from molecular genetics to prevention. Application to insulin-dependent diabetes mellitus.
    Bach JF
    Isr J Med Sci; 1992 Feb; 28(2):111-2. PubMed ID: 1559793
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunosuppression in juvenile diabetes mellitus? Critical viewpoint on the treatment with cyclosporin A with consideration of the differential etiology].
    Teuber J; Usadel KH
    Fortschr Med; 1985 Jul; 103(27-28):707-13. PubMed ID: 4029865
    [No Abstract]   [Full Text] [Related]  

  • 38. Potential role of immunoablation and hematopoietic cell transplantation in the treatment of early diabetes type 1.
    Snarski E; Milczarczyk A; Franek E; Jedrzejczak W
    Ann Transplant; 2010; 15(3):75-9. PubMed ID: 20877271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunotherapy of insulin-dependent diabetes mellitus].
    Satoh J; Seino H; Shintani S; Toyota T
    Nihon Rinsho; 1991 Feb; 49 Suppl():519-24. PubMed ID: 2033845
    [No Abstract]   [Full Text] [Related]  

  • 40. Diabetes and immunology: pathogenesis and immunotherapy.
    Curr Probl Clin Biochem; 1983; 12():1-144. PubMed ID: 6653139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.